Concourse Financial Group Securities, Inc. Biotechnology

Concourse Financial Group Securities, Inc.

$0
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
SEER Seer, Inc.	$128M	$0 100.0% of portfolio	0	Q1 2025 New
SLS Sellas Life Sciences Group, Inc.	$33.7M	$0 100.0% of portfolio	0	Q1 2025 New
SNSE Sensei Biotherapeutics, Inc.	$10.4M	$0 100.0% of portfolio	0	Q1 2025 New
MCRB Seres Therapeutics, Inc.	$923M	$0 100.0% of portfolio	0	Q1 2025 New
SESN Sesen Bio, Inc.	$127M	$0 100.0% of portfolio	0	Q1 2025 New
STTK Shattuck Labs, Inc.	$48.3M	$0 100.0% of portfolio	0	Q1 2025 New
SLN Silence Therapeutics PLC	$198M	$0 100.0% of portfolio	0	Q1 2025 New
SILO Silo Pharma, Inc.	$1.57M	$0 100.0% of portfolio	0	Q1 2025 New
SBTX Silverback Therapeutics, Inc.	$0	$0 100.0% of portfolio	0	Q1 2025 New
SIOX Sio Gene Therapies Inc.	$0	$0 100.0% of portfolio	0	Q1 2025 New
SLGL Sol Gel Technologies Ltd.	$170M	$0 100.0% of portfolio	0	Q1 2025 New
SNGX Soligenix, Inc.	$84.1M	$0 100.0% of portfolio	0	Q1 2025 New
SRNE Sorrento Therapeutics, Inc.	$148M	$0 100.0% of portfolio	0	Q1 2025 New
SPRO Spero Therapeutics, Inc.	$92.6M	$0 100.0% of portfolio	0	Q1 2025 New
SWTX Spring Works Therapeutics, Inc.	$2.92B	$0 100.0% of portfolio	0	Q1 2025 New
SPRB Spruce Biosciences, Inc.	$1.41M	$0 100.0% of portfolio	0	Q1 2025 New
STAB Statera Biopharma, Inc.	$0	$0 100.0% of portfolio	0	Q1 2025 New
STOK Stoke Therapeutics, Inc.	$429M	$0 100.0% of portfolio	0	Q1 2025 New
SMMT Summit Therapeutics Inc.	$3.97B	$0 100.0% of portfolio	0	Q1 2025 New
SRZNW Surrozen Inc Wt Exp 08/01/31 (	$0	$0 100.0% of portfolio	0	Q1 2025 New
STRO Sutro Biopharma, Inc.	$44.3M	$0 100.0% of portfolio	0	Q1 2025 New
SNDX Syndax Pharmaceuticals Inc	$631M	$0 100.0% of portfolio	0	Q1 2025 New
TNGX Tango Therapeutics, Inc.	$309M	$0 100.0% of portfolio	0	Q1 2025 New
TARS Tarsus Pharmaceuticals, Inc.	$1.2B	$0 100.0% of portfolio	0	Q1 2025 New
TSHA Taysha Gene Therapies, Inc.	$140M	$0 100.0% of portfolio	0	Q1 2025 New
TPST Tempest Therapeutics, Inc.	$71M	$0 100.0% of portfolio	0	Q1 2025 New
TNYA Tenaya Therapeutics, Inc.	$24.8M	$0 100.0% of portfolio	0	Q1 2025 New
TERN Terns Pharmaceuticals, Inc.	$134M	$0 100.0% of portfolio	0	Q1 2025 New
TGTX Tg Therapeutics, Inc.	$5.71B	$0 100.0% of portfolio	0	Q1 2025 New
TBPH Theravance Biopharma, Inc.	$719M	$0 100.0% of portfolio	0	Q1 2025 New
THRD Third Harmonic Bio, Inc.	$210M	$0 100.0% of portfolio	0	Q1 2025 New
TLSA Tiziana Life Sciences LTD	$146M	$0 100.0% of portfolio	0	Q1 2025 New
TVTX Travere Therapeutics, Inc.	$945M	$0 100.0% of portfolio	0	Q1 2025 New
TRVI Trevi Therapeutics, Inc.	$353M	$0 100.0% of portfolio	0	Q1 2025 New
TCDA Tricida, Inc.	$557K	$0 100.0% of portfolio	0	Q1 2025 New
TCRX T Scan Therapeutics, Inc.	$32M	$0 100.0% of portfolio	0	Q1 2025 New
TYRA Tyra Biosciences, Inc.	$445M	$0 100.0% of portfolio	0	Q1 2025 New
RARE Ultragenyx Pharmaceutical Inc.	$2.59B	$0 100.0% of portfolio	0	Q1 2025 New
UNCY Unicycive Therapeutics, Inc.	$11.4M	$0 100.0% of portfolio	0	Q1 2025 New
QURE Uni Qure N.V.	$776M	$0 100.0% of portfolio	0	Q1 2025 New
UTHR United Therapeutics Corp	$14.6B	$0 100.0% of portfolio	0	Q1 2025 New
URGN Uro Gen Pharma Ltd.	$131M	$0 100.0% of portfolio	0	Q1 2025 New
VACC Vaccitech PLC	$127M	$0 100.0% of portfolio	0	Q1 2025 New
VALN Valneva Se	$434M	$0 100.0% of portfolio	0	Q1 2025 New
VNDA Vanda Pharmaceuticals Inc.	$248M	$0 100.0% of portfolio	0	Q1 2025 New
VXRT Vaxart, Inc.	$50.6M	$0 100.0% of portfolio	0	Q1 2025 New
PCVX Vaxcyte, Inc.	$2.06B	$0 100.0% of portfolio	0	Q1 2025 Sold Out
VTYX Ventyx Biosciences, Inc.	$127M	$0 100.0% of portfolio	0	Q1 2025 New
VERA Vera Therapeutics, Inc.	$567M	$0 100.0% of portfolio	0	Q1 2025 New
VCYT Veracyte, Inc.	$1.93B	$0 100.0% of portfolio	0	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.